Pharmacokinetics of DI-Leu16-IL-2 before and after deglycosylation. A time-concentration analysis was performed following a moderate intravenous dose of each immunocytokine. Serum concentrations were determined by an ELISA that detects the intact forms for the native (▪) and deglycosylated proteins (○).